A newly approved vaccine for older adults, as well as other potential treatments to protect infants, could make a monumental difference in the number of people being hospitalized and dying from RSV, infectious disease and public health experts say.
A newly approved vaccine for older adults, as well as other potential treatments to protect infants, could make a monumental difference in the number of people being hospitalized and dying from RSV, infectious disease and public health experts say.
Post a Comment
EmoticonClick to see the code!
To insert emoticon you must added at least one space before the code.